欢迎光临~北京凯森莱科技有限公司
语言选择: 中文版 ∷  英文版
  • 123155-04-4 , 2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin
123155-04-4 , 2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin

123155-04-4 , 2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin

123155-04-4 , 2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin ,
2,3-Di-O-methyl-6-O-tert-butyldimethylsilyl)cyclomaltoheptaose;
Heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-b-cyclodextrin,
Cas:123155-04-4
C98H196O35Si7 / 2131.18

2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin , 

2,3-Di-O-methyl-6-O-tert-butyldimethylsilyl)cyclomaltoheptaose; Heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-b-cyclodextrin

Heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-|A-cyclodextrin (hepta-CD) is a cyclic oligosaccharide that consists of seven |D-glucopyranose units that are linked by α-1,4-glycosidic bonds. Cyclodextrins (CDs) are widely used as pharmaceutical excipients, drug delivery vehicles, and chiral selectors. They are also used as food additives, cosmetic ingredients, and in the production of fragrances.

Hepta-CD is an α-CD derivative that has been modified with 2,3-di-O-methyl and 6-O-tert-butyldimethylsilyl substituents. These substitutions alter the physical and chemical properties of the CD, resulting in improved solubility, stability, and selectivity. Hepta-CD has attracted considerable attention in various scientific and industrial fields due to its unique properties and potential applications.

Synthesis and Characterization

Hepta-CD can be synthesized by various methods, including enzymatic synthesis, chemical modification, and host-guest complexation. Enzymatic synthesis involves the use of cyclodextrin glucanotransferase (CGTase) to transfer glucosyl units from starch to form CDs. Chemical modification involves the reaction of CDs with functionalized reagents to introduce substituents. Host-guest complexation involves the inclusion of guest molecules into the CD cavity to form inclusion complexes.

The structure and properties of hepta-CD can be characterized by various techniques, including ^1H NMR spectroscopy, mass spectrometry, X-ray crystallography, and thermal analysis. ^1H NMR spectroscopy is a widely used technique to determine the degree of substitution and the inclusion properties of CDs. Mass spectrometry is used to confirm the molecular weight and the degree of substitution of the CD. X-ray crystallography is used to determine the three-dimensional structure of the CD and its inclusion complexes. Thermal analysis is used to determine the thermal stability and the phase transition behavior of the CD.

Analytical Methods

Hepta-CD can be analyzed by various analytical methods, including chromatography, spectrophotometry, and electrophoresis. Chromatography techniques such as high-performance liquid chromatography (HPLC) and gas chromatography (GC) are used to separate and quantify the CD and its derivatives. Spectrophotometry techniques such as UV-Vis spectroscopy and fluorescence spectroscopy are used to measure the inclusion properties and the binding constants of the CD with guest molecules. Electrophoresis techniques such as capillary electrophoresis (CE) and polyacrylamide gel electrophoresis (PAGE) are used to separate and analyze the CD and its complexation with other molecules.

Biological Properties

Hepta-CD has been shown to have various biological properties, including antimicrobial, anticancer, and anti-inflammatory activities. The inclusion of hepta-CD with bioactive molecules can enhance their solubility and stability, resulting in improved biological activity. The hydrophobic cavity of hepta-CD can also selectively bind to lipophilic molecules such as steroids and fatty acids.

Toxicity and Safety in Scientific Experiments

Hepta-CD has been shown to exhibit low toxicity and high biocompatibility in scientific experiments. The LD50 (lethal dose for 50% of tested animals) of hepta-CD is greater than 5000 mg/kg in mice and rats. Hepta-CD has been used as a chiral selector in separation science and as a pharmaceutical excipient in drug delivery without any significant toxicity issues reported.

Applications in Scientific Experiments

Hepta-CD has a wide range of applications in scientific experiments, including separation science, pharmaceuticals, and materials science. Hepta-CD can be used as a chiral selector in HPLC and CE to separate enantiomers of chiral compounds. Hepta-CD can be used as a drug delivery vehicle to improve the solubility, stability, and bioavailability of poorly water-soluble drugs. Hepta-CD can also be used as a building block in supramolecular chemistry to construct novel functional materials.

Current State of Research

The research on hepta-CD has been extensive, and it has led to significant achievements in various fields. The synthesis and characterization of hepta-CD and its derivatives have been well-established, and their inclusion properties have been studied extensively. Hepta-CD has been used as a pharmaceutical excipient and a drug delivery vehicle in several drug formulations. Hepta-CD has also been explored as a building block in supramolecular chemistry to construct functional nanostructures.

Potential Implications in Various Fields of Research and Industry

Hepta-CD has the potential to impact various fields of research and industry, including pharmaceuticals, separation science, and materials science. Hepta-CD can improve the efficacy and safety of drug formulations by improving their solubility, stability, and bioavailability. Hepta-CD can also be used to separate chiral compounds in HPLC and CE, which is critical in drug development and manufacturing. Hepta-CD can be used as a building block to construct smart materials such as molecular devices and sensors.

Limitations and Future Directions

Despite the significant achievements in the research on hepta-CD, there are still limitations and future directions to be considered. One limitation is the cost of hepta-CD synthesis and production, which may affect its widespread use in various applications. Another limitation is the lack of studies on the environmental impact of hepta-CD and its derivatives. Future directions could include the exploration of new synthetic methods for hepta-CD and its derivatives to reduce costs and improve efficiency. Another direction could be the investigation of hepta-CD's interaction with biological systems and its potential use in biotechnology and medicine. An additional future direction could include examining the environmental impact of hepta-CD and its derivatives, especially in water systems.

In conclusion, hepta-CD is a cyclic oligosaccharide that has unique physical and chemical properties, making it useful in various scientific and industrial applications. The synthesis and characterization of hepta-CD and its derivatives have been well-documented, and their inclusion properties have been studied extensively. Hepta-CD has shown promise in improving drug formulations and constructing novel materials. However, the limitations of hepta-CD and the future directions for its research should be considered to pave the way for its successful application in the future.

CAS Number123155-04-4
Product NameHeptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-|A-cyclodextrin
IUPAC Nametert-butyl-[[(1R,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31R,33R,35R,36R,37R,38R,39R,40S,41R,42R,43R,45R,47R,49R)-10,15,20,25,30,35-hexakis[[tert-butyl(dimethyl)silyl]oxymethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methoxy]-dimethylsilane
Molecular FormulaC₉₈H₁₉₆O₃₅Si₇
Molecular Weight2131.18
InChIInChI=1S/C98H196O35Si7/c1-92(2,3)134(36,37)113-50-57-64-71(99-22)78(106-29)85(120-57)128-65-58(51-114-135(38,39)93(4,5)6)122-87(80(108-31)72(65)100-23)130-67-60(53-116-137(42,43)95(10,11)12)124-89(82(110-33)74(67)102-25)132-69-62(55-118-139(46,47)97(16,17)18)126-91(84(112-35)76(69)104-27)133-70-63(56-119-140(48,49)98(19,20)21)125-90(83(111-34)77(70)105-28)131-68-61(54-117-138(44,45)96(13,14)15)123-88(81(109-32)75(68)103-26)129-66-59(52-115-136(40,41)94(7,8)9)121-86(127-64)79(107-30)73(66)101-24/h57-91H,50-56H2,1-49H3/t57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73?,74+,75?,76-,77?,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-/m1/s1
SMILESCC(C)(C)[Si](C)(C)OCC1C2C(C(C(O1)OC3C(OC(C(C3OC)OC)OC4C(OC(C(C4OC)OC)OC5C(OC(C(C5OC)OC)OC6C(OC(C(C6OC)OC)OC7C(OC(C(C7OC)OC)OC8C(OC(O2)C(C8OC)OC)CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)OC)OC
Synonyms6A,6B,6C,6D,6E,6F,6G-Heptakis-O-[(1,1-dimethylethyl)dimethylsilyl]-2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-tetradeca-O-methyl-β-cyclodextrin; 2,3-Di-O-methyl-6-O-tert-butyldimethylsilyl-β-cyclodextrin; Heptakis(2,3-di-O-methyl-6-O-tert-butyldimethy


在线询价

用手机扫描二维码关闭
二维码